What mitochondrial depletion means for egg quality — and how both Western medicine and acupuncture are working to turn the tide
A guide for those navigating diminished ovarian reserve and age-related fertility challenges
If you’ve been told your egg quality is declining — whether due to age, a diagnosis of diminished ovarian reserve (DOR), or simply years of unexplained infertility — you may have heard that there is very little that can be done. That your eggs are what they are. But a deeper look at the biology tells a more nuanced, and in some ways more hopeful, story.
At the center of that story is a tiny structure you probably last thought about in high school biology: the mitochondrion. Often called the cell’s “powerhouse,” mitochondria are the energy factories that keep every cell in your body running. And in your eggs, they are uniquely, critically important.
Understanding what happens when those energy factories falter — and what we can do about it — is one of the most active frontiers in reproductive medicine today.
A human egg, or oocyte, contains more mitochondria than virtually any other cell in the body — somewhere between 100,000 and 600,000 of them, depending on the egg’s maturity and health. This is not accidental. The egg must be prepared to fuel not just itself, but an entirely new organism through the explosive cellular divisions of early embryo development — all before a pregnancy has even been confirmed.
That fuel is a molecule called adenosine triphosphate, or ATP. Think of ATP as the universal energy currency of life. Every time a cell needs to do something — divide, repair itself, build a protein, maintain its internal architecture — it spends ATP. Mitochondria are the engines that produce it.
| THE KEY NUMBER Studies suggest a healthy, fertilizable oocyte needs to produce sufficient ATP to support early embryonic development across the first several cell divisions. Eggs with depleted mitochondrial activity produce less ATP — and the consequences cascade from there: poor fertilization rates, arrested embryo development, failed implantation, and early miscarriage. |
Beyond quantity, mitochondrial quality and location matter too. In healthy eggs, mitochondria are distributed throughout the cell in organized patterns and are structurally intact. In aging or compromised eggs, mitochondria often cluster abnormally, swell, and lose their internal structures. They become, in short, bad power plants.
Mitochondrial depletion and dysfunction in oocytes isn’t a single event — it’s the cumulative result of several biological processes, some inevitable and some modifiable. Here is what the research has identified:
“The egg doesn’t fail all at once. It fails quietly, incrementally, at the level of energy production — long before any scan or blood test can detect it.”
Conventional reproductive medicine has made significant strides in understanding and addressing mitochondrial egg quality. It is important to be clear-eyed about what is well-evidenced versus what is still emerging or experimental.
CoQ10 is perhaps the most evidence-supported mitochondrial supplement for egg quality. It functions both as a critical component of the mitochondrial electron transport chain and as a powerful antioxidant that protects mitochondria from oxidative damage. As the body’s natural CoQ10 levels decline with age, supplementation may help compensate. Several clinical studies have found that CoQ10 supplementation in older women undergoing IVF was associated with improved oocyte quality, fertilization rates, and embryo quality.
The form ubiquinol (the reduced, active form of CoQ10) is generally considered more bioavailable.
| TYPICAL APPROACH Doses in fertility research range from 200–600 mg/day, often started 2–3 months before an IVF cycle — since oocyte maturation takes approximately 90 days. Always discuss dosage with your reproductive endocrinologist. |
DHEA, a weak androgen produced by the adrenal glands, has shown promise for women with DOR. Multiple studies report that pre-treatment with DHEA (typically 25–75 mg/day for 3–6 months) improves ovarian response to stimulation, increases egg numbers, and may improve embryo quality.
Known as the sleep hormone, melatonin is also a potent antioxidant that accumulates in follicular fluid. Studies have shown that melatonin supplementation can reduce oxidative damage within follicles, improving oocyte quality in women undergoing IVF — particularly those with elevated oxidative stress markers.
This naturally occurring compound, often paired with folic acid, plays a role in follicle-stimulating hormone (FSH) signal transduction within the ovary. Clinical trials have shown improvements in oocyte quality, fertilization rates, and embryo quality — particularly in women with poor ovarian response.
NAD+ is essential for mitochondrial function and plays a key role in proteins that regulate cellular aging. Animal studies — most prominently from David Sinclair’s lab at Harvard — have shown striking improvements in oocyte quality and fertility with NMN supplementation. Human trials are in early stages, but this is one of the most actively researched areas in reproductive aging biology.
The most radical mitochondrial intervention — transferring healthy mitochondria from donor cells into aging eggs — has shown promise in early research but remains experimental and is not approved for clinical use in most countries. The field continues to evolve rapidly.
Most reproductive endocrinologists also recommend antioxidant-rich diets (Mediterranean-style), avoidance of smoking and alcohol, weight optimization, stress management, and adequate sleep — all of which reduce oxidative burden and support mitochondrial health systemically.
Acupuncture — the insertion of fine needles into specific anatomical locations on the body to influence physiological processes — is one of the most studied complementary therapies in reproductive medicine. Several biological pathways have been identified that connect acupuncture to exactly the mitochondrial and energetic processes we’ve been discussing.
One of the most well-replicated findings in acupuncture research is its effect on circulation. Studies using transvaginal Doppler ultrasound have shown that acupuncture can measurably increase blood flow to the uterus and ovaries. Better perfusion means more oxygen and nutrients — including the CoQ10 and other cofactors mitochondria depend on — delivered directly to the follicular environment.
| THE BLOOD FLOW CONNECTION A landmark study by Stener-Victorin and colleagues demonstrated that electroacupuncture could modulate sympathetic nerve activity in the ovaries — the same nervous system pathway that constricts blood vessels under stress — resulting in measurable increases in ovarian blood flow. In women with poor ovarian response, compromised follicular blood flow is a known contributor to mitochondrial dysfunction. |
Chronic psychological stress floods the system with cortisol, which in high concentrations impairs mitochondrial function and increases systemic oxidative stress. Multiple studies have demonstrated that acupuncture significantly reduces cortisol levels, calms the nervous system, and promotes the relaxation response — the physiological state in which mitochondrial repair and regeneration are most active.
Several studies have shown that acupuncture needle stimulation triggers a measurable release of ATP at the site of insertion.
This local ATP acts as a signaling molecule, activating receptors that cascade into broader cellular energy regulation effects. Electroacupuncture has shown direct activation of AMPK (AMP-activated protein kinase) — a cellular energy sensor that triggers the creation of new mitochondria and enhances ATP production efficiency. AMPK is sometimes called the “master energy switch” of the cell.
Studies have shown that acupuncture can reduce markers of systemic and local inflammation and upregulate the body’s own antioxidant enzymes — the very defenses that protect mitochondrial membranes from oxidative damage in the follicular environment.
Acupuncture has been shown to influence the hormonal cascade that governs ovarian function — affecting the balance of FSH, LH, and GnRH signaling that drives follicular development. By helping to normalize these hormonal rhythms, acupuncture may create a more favorable environment for oocyte development and mitochondrial function within maturing eggs.
| A NOTE ON TIMING In integrative fertility practice, acupuncture for egg quality is typically recommended for a minimum of 3 months prior to attempting conception or beginning an IVF cycle — aligning with the approximately 90-day window of oocyte maturation. Weekly or twice-weekly sessions are the most common protocol, tailored to each patient’s hormonal profile and fertility history. |
Western and integrative approaches to mitochondrial egg quality are not mutually exclusive — and for many women navigating fertility challenges, the most effective path combines the two. Here is how they compare:
WESTERN MEDICINE APPROACHES – CoQ10 / ubiquinol supplementation (direct mitochondrial cofactor) – DHEA pre-treatment (3–6 months before IVF) – Melatonin (antioxidant, follicular fluid) – Myo-inositol + folic acid – NAD+ precursors (NMN/NR) — emerging evidence – Antioxidant-rich diet (Mediterranean-style) – Mitochondrial transfer — experimental only – Optimized IVF protocols (minimal stimulation options) | ACUPUNCTURE & INTEGRATIVE APPROACHES – Increased ovarian and uterine blood flow (Doppler-confirmed) – Reduced cortisol and nervous system calming – AMPK activation → mitochondrial biogenesis – Local ATP release at needle sites – Upregulation of the body’s own antioxidant defenses – Reduction of inflammatory markers – FSH/LH hormonal balance support – Electroacupuncture for enhanced mitochondrial signaling |
The core difference is worth noting: Western medicine largely works by supplying what the mitochondria need from the outside — cofactors, antioxidants, hormones. Acupuncture works more by signaling the body to activate its own mitochondrial repair and energy production machinery. Both approaches are ultimately trying to do the same thing: give the egg enough energy to fulfill its extraordinary purpose.
Navigating fertility challenges — especially when age or DOR is part of the picture — can feel like running out of time. But the biology of mitochondrial health offers something important: a window of influence. The 90-day period before ovulation during which each egg matures is a real, biological opportunity for intervention.
None of these approaches — Western or integrative — are magic. They work at the margins of biology, nudging cellular energy systems in the right direction. But at the margins of fertility, those nudges can matter enormously.
The best evidence supports a multi-modal approach: working with a reproductive endocrinologist who is open to evidence-based supplementation and partnering with a licensed acupuncturist who specializes in fertility. The two paradigms, when working together, address mitochondrial health from more angles than either can alone.
THE BERKLEY CENTER FOR REPRODUCTIVE WELLNESS Ready to take the next step? Our integrative approach combines the latest in reproductive science with evidence-based acupuncture and nutritional support — all under one roof, in the heart of Manhattan. We work with you and your fertility team to create a personalized plan for optimizing egg quality. Call us: 212-685-0985 16 East 40th Street, New York, NY 10016 |
The following studies and reviews informed this article. Research in mitochondrial reproductive biology is rapidly evolving; this list reflects key findings as of early 2025.
1. Bentov Y, et al. “The use of mitochondrial nutrients to improve the outcome of infertility treatment in older patients.” Fertility and Sterility, 2010;93(1):272–275.
2. Casper RF, et al. “CoQ10 and the aging oocyte.” Fertility and Sterility, 2011.
3. Ben-Meir A, et al. “Coenzyme Q10 restores oocyte mitochondrial function and fertility during reproductive aging.” Aging Cell, 2015;14(5):887–895.
4. Barad D & Gleicher N. “Effect of dehydroepiandrosterone on oocyte and embryo yields, embryo grade and cell number in IVF.” Human Reproduction, 2006;21(11):2845–2849.
5. Tamura H, et al. “Oxidative stress impairs oocyte quality and melatonin protects oocytes from free radical damage.” Journal of Pineal Research, 2008;44(3):280–287.
6. Xu Y, et al. “Mitochondria in different cells of follicular development and pathological oocytes.” Cell Proliferation, 2015.
7. Niu YJ, et al. “Nicotinamide mononucleotide protects oocyte quality through reversing mitochondrial dysfunction in aged mice.” Cell Reports, 2022;41(8):111612.
8. Miao Y, et al. “Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha.” Cell Metabolism, 2013.
9. Stener-Victorin E, et al. “Effects of electro-acupuncture on nerve fibers, ovarian blood flow and steroid output in rats with steroid-induced polycystic ovaries.” Biology of Reproduction, 2003;69(6):1800–1806.
10. Ho M, et al. “Electroacupuncture reduces uterine artery blood flow impedance in infertile women.” Taiwanese Journal of Obstetrics and Gynecology, 2009;48(2):148–151.
11. Zhao ZQ. “Neural mechanism underlying acupuncture analgesia.” Progress in Neurobiology, 2008;85(4):355–375.
12. Yin J & Chen JDZ. “Gastrointestinal motility disorders and acupuncture.” Autonomic Neuroscience, 2010.
13. Zhu J, et al. “Acupuncture decreases serum levels of FSH and increases AFC in DOR patients: a randomized controlled pilot study.” Acupuncture in Medicine, 2019.
14. Chao SL, et al. “A randomized controlled trial of acupuncture for IVF outcomes: influence on mitochondrial DNA copy number and oxidative stress markers in follicular fluid.” Journal of Acupuncture and Meridian Studies, 2021.
15. Speroff L & Fritz MA. Clinical Gynecologic Endocrinology and Infertility, 8th ed. Lippincott Williams & Wilkins, 2011.
16. Wesselink AK, et al. “Dietary antioxidant intake and fecundability in a North American preconception cohort study.” Reproductive BioMedicine Online, 2019;39(5):835–845.
17. Revelli A, et al. “Follicular fluid content and oocyte quality: from single biochemical markers to metabolomics.” Reproductive Biology and Endocrinology, 2009;7:40.
